Bowel Ischaemia. How does it present and what should I do?
6th August 2020
Overview
Ischaemic bowel disease encompasses a heterogeneous group of disorders either acute or chronic, arising from occlusive or non-occlusive aetiologies, which result in decreased blood flow to the gastrointestinal tract. The clinical course may range from mild, transient and reversible to fulminant and life threatening. In acute mesenteric ischaemia prompt action is required to diagnose and treat as outcomes can be poor.
This webinar will help you understand when to consider bowel ischaemia as a diagnosis, how to investigate, and how to manage this challenging group of disorders.
Speakers
Mr Stephen Boyce
Stephen Boyce is a Consultant Colorectal surgeon trained in Edinburgh, Brisbane and Sydney with a passion for minimally invasive, laparoscopic and robotic surgery for colorectal cancer. He is a Regional Surgical Advisor for the RCSEd.
Miss Farhat Din
Farhat Din is a consultant colorectal surgeon at the Western General Hospital and Honorary Senior Lecturer at Edinburgh University.Farhat’s translational research portfolio, encompassing both basic laboratory research and clinical studies, focuses on colorectal cancer prevention by investigating energy and metabolism pathways that are associated with risk factors such as obesity and physical inactivity. She was awarded a Cancer Research UK Clinician Scientist Fellowship in 2010 and currently holds a Chief Scientist Office Senior Clinical Fellowship (2017-2021).
In addition to her translational laboratory research, Farhat is actively involved in clinical trials, being the local principle investigator on several national trials. Alongside her clinical practice and research activities, Farhat has a keen interest in surgical career development, being an enthusiastic tutor and mentor for both medical students and surgical trainees. She has contributed to RCSEd through previous Regional Surgical Advisor and Younger Fellows roles, and currently contributes to multiple grant committees and collaborations including RCSEd, Tenovus, the Scottish Cancer Foundation, the Melville Trust and the UK Therapeutic Cancer Prevention Network. She is part of the CRUK Clinical Careers Committee which is responsible for clinician scientist fellowships and clinical bursaries.
Recording
